| Training set (n = 680) |  | Testing set (n = 169) | ||||||
---|---|---|---|---|---|---|---|---|---|
Benign tumour(n = 440) | BOTs(n = 44) | Malignant tumour(n = 196) | P |  | Benign tumour(n = 109) | BOTs(n = 11) | Malignant tumour(n = 49) | P | |
age (y) | 37.07 ± 12.38 | 42.16 ± 13.71 | 49.63 ± 13.59 | < 0.001* |  | 38.70 ± 14.13 | 39.64 ± 14.66 | 48.47 ± 10.41 | < 0.001* |
Height (m) | 1.58 ± 0.06 | 1.58 ± 0.058 | 1.56 ± 0.06 | < 0.001* |  | 1.57 ± 0.06 | 1.58 ± 0.03 | 1.56 ± 0.04 | 0.110 |
Weight (kg) | 54.67 ± 9.54 | 56.51 ± 8.49 | 55.16 ± 9.01 | 0.468 |  | 55.85 ± 9.25 | 55.11 ± 11.13 | 54.68 ± 9.52 | 0.467 |
BMI | 21.95 ± 3.56 | 22.68 ± 3.25 | 22.65 ± 3.29 | 0.014* |  | 22.53 ± 3.58 | 22.12 ± 3.97 | 22.46 ± 3.73 | 0.882 |
RBC_count (1012/L) | 4.55 ± 0.53 | 4.46 ± 0.41 | 4.36 ± 0.57 | < 0.001* |  | 4.31 ± 0.55 | 4.41 ± 0.55 | 4.30 ± 0.54 | 0.975 |
WBC_count (109/L) | 7.03 ± 2.00 | 6.80 ± 2.20 | 7.79 ± 2.58 | < 0.001* |  | 7.26 ± 2.77 | 6.20 ± 0.94 | 7.11 ± 1.74 | 0.623 |
Neutrophil_count (109/L) | 4.18 ± 1.788 | 4.31 ± 2.16 | 5.22 ± 2.44 | < 0.001* |  | 4.52 ± 2.62 | 3.18 ± 0.89 | 4.72 ± 1.89 | 0.780 |
Lymphocyte_count (109/L) | 2.12 ± 0.62 | 1.87 ± 0.63 | 1.78 ± 0.74 | < 0.001* |  | 2.06 ± 0.70 | 2.32 ± 0.74 | 2.03 ± 1.15 | 0.906 |
Monocyte_count (109/L) | 0.63 ± 0.28 | 0.55 ± 0.25 | 0.64 ± 0.28 | 0.852 |  | 0.49 ± 0.19 | 0.52 ± 0.15 | 0.51 ± 0.23 | 0.564 |
PLT_count (109/L) | 296.91 ± 72.08 | 275.25 ± 56.68 | 345.37 ± 115.83 | < 0.001* |  | 282.19 ± 65.22 | 275.09 ± 82.76 | 340.04 ± 89.81 | < 0.001* |
Hemoglobin(g/L) | 124.44 ± 18.09 | 123.34 ± 14.20 | 117.22 ± 16.54 | < 0.001* |  | 119.75 ± 16.99 | 117.18 ± 21.75 | 114.90 ± 16.21 | 0.097 |
NLR | 2.20 ± 1.59 | 2.91 ± 2.73 | 3.51 ± 2.43 | < 0.001* |  | 2.72 ± 3.17 | 1.56 ± 0.75 | 2.78 ± 1.91 | 0.991 |
PLR | 154.04 ± 83.09 | 168.43 ± 94.34 | 228.71 ± 137.61 | < 0.001* |  | 151.78 ± 64.23 | 130.95 ± 53.74 | 200.41 ± 118.78 | 0.002* |
LMR | 3.82 ± 1.62 | 3.87 ± 1.63 | 3.40 ± 2.60 | 0.016* |  | 4.51 ± 1.69 | 4.72 ± 1.96 | 4.29 ± 1.76 | 0.510 |
dNLR | 1.57 ± 1.14 | 1.76 ± 2.50 | 5.61 ± 47.72 | 0.073 |  | 1.88 ± 1.66 | 1.15 ± 0.51 | 1.99 ± 1.53 | 0.799 |
SII | 663.44 ± 534.53 | 807.60 ± 843.56 | 1258.88 ± 1026.20 | < 0.001* |  | 752.95 ± 916.38 | 430.17 ± 211.21 | 969.97 ± 779.50 | 0.190 |
Menopausal_state, n (%) |  |  |  | < 0.001* |  |  |  |  | < 0.001* |
Premenopausal | 383(87.05%) | 28(63.64%) | 102(52.04%) | Â | Â | 90(82.57%) | 9(81.82%) | 25(51.02%) | Â |
Menopause | 57(12.95%) | 16(36.36%) | 94(47.96%) | Â | Â | 19(17.43%) | 2(18.18%) | 24(48.98%) | Â |
Tumour_diameter (mm), n (%) |  |  |  | < 0.001* |  |  |  |  | 0.001* |
≤ 50 | 68(15.45%) | 6(13.64%) | 12(6.12%) |  |  | 21(19.27%) | 1(9.09%) | 1(2.04%) |  |
50–100 | 293(66.59%) | 18(40.91%) | 79(40.31%) |  |  | 59(54.13%) | 5(45.45%) | 20(40.82%) |  |
≥ 100 | 79(17.95%) | 20(45.45%) | 105(53.57%) |  |  | 29(26.61%) | 5(45.45%) | 28(57.14%) |  |
Mass_characteristicn, n (%) |  |  |  | < 0.001* |  |  |  |  | < 0.001* |
Cystic | 314(71.36%) | 18(40.91%) | 13(6.63%) | Â | Â | 79(72.48%) | 4(36.36%) | 1(2.04%) | Â |
Cystic-solid mixed | 102(23.18%) | 21(47.73%) | 89(45.41%) | Â | Â | 23(21.10%) | 6(54.55%) | 30(61.22%) | Â |
Solid | 24(5.45%) | 5(11.36%) | 94(47.96%) | Â | Â | 7(6.42%) | 1(9.09%) | 18(36.73%) | Â |
colour_score, n (%) |  |  |  | < 0.001* |  |  |  |  | < 0.001* |
1 | 401(91.14%) | 8(18.18%) | 11(5.61%) | Â | Â | 83(76.15%) | 4(36.36%) | 2(4.08%) | Â |
2 | 35(7.95%) | 24(54.55%) | 77(39.29%) | Â | Â | 21(19.27%) | 7(63.64%) | 22(44.90%) | Â |
3 | 4(0.91%) | 10(22.73%) | 91(46.43%) | Â | Â | 4(3.67%) | 0 | 25(51.02%) | Â |
4 | 0 | 2(4.55%) | 17(8.67%) | Â | Â | 1(0.92%) | 0 | 0 | Â |
Ascites, n (%) |  |  |  | < 0.001* |  |  |  |  | < 0.001* |
No | 437(99.32%) | 39(88.64%) | 138(70.41%) | Â | Â | 107(98.17%) | 11(100.00%) | 40(81.63%) | Â |
Yes | 3(0.68%) | 5(11.36%) | 58(29.59%) | Â | Â | 2(1.83%) | 0 | 9(18.37%) | Â |
Tumour_side, n (%) |  |  |  | < 0.001* |  |  |  |  | 0.072 |
Unilateral | 379(86.14%) | 42(95.45%) | 124(63.27%) | Â | Â | 99(90.83%) | 9(81.82%) | 38(77.55%) | Â |
Bilateral | 61(13.86%) | 2(4.55%) | 72(36.73%) | Â | Â | 10(9.17%) | 2(18.18%) | 11(22.45%) | Â |
CA125_level (U/ml), n (%) |  |  |  | < 0.001* |  |  |  |  | < 0.001* |
≤ 35 | 304(69.09%) | 27(61.36%) | 46(23.47%) |  |  | 80(73.39%) | 6(54.55%) | 14(28.57%) |  |
>35, ≤ 200 | 115(26.14%) | 11(25.00%) | 51(26.02%) |  |  | 26(23.85%) | 4(36.36%) | 13(26.53%) |  |
>200, <500 | 16(3.64%) | 2(4.55%) | 34(17.35%) | Â | Â | 2(1.83%) | 0 | 8(16.33%) | Â |
≥ 500 | 5(1.14%) | 4(9.09%) | 65(33.16%) |  |  | 1(0.92%) | 1(9.09%) | 14(28.57%) |  |